Clinical and Histological Features of Idiosyncratic Acute Liver Injury Caused by Temozolomide.
Dig. Dis. Sci., Dec (2012)
Prevalence and morbidity associated with muscle cramps in patients with cirrhosis.
Am. J. Med., Oct;125(10):1019-25 (2012)
Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin.
Eur. J. Clin. Pharmacol., Jul (2012)
Acute liver injury due to flavocoxid (Limbrel), a medical food for osteoarthritis: a case series.
Ann. Intern. Med., Jun;156(12):857-60, W297-300 (2012)
Dyslipidemia in patients with nonalcoholic fatty liver disease.
Semin. Liver Dis., Feb;32(1):22-9 (2012)
Oxidative stress in chronic liver disease: relationship between peripheral and hepatic measurements.
Am. J. Med. Sci., Oct;342(4):314-7 (2011)
Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes.
J. Clin. Gastroenterol., Oct;45(9):800-7 (2011)
Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network.
Hepatol Int., May (2011)
Clinical and histopathologic features of fluoroquinolone-induced liver injury.
Clin. Gastroenterol. Hepatol., Jun;9(6):517-523.e3 (2011)
Hepatic and extrahepatic cancer in cirrhosis: a longitudinal cohort study.
Am. J. Gastroenterol., May;106(5):899-906 (2011)
Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease.
J. Hepatol., Sep;55(3):654-9 (2011)
Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease.
Clin. Gastroenterol. Hepatol., Mar;9(3):254-9 (2011)
Drug-induced QT prolongation in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
J. Clin. Gastroenterol., Aug;45(7):638-42 (2011)
Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease.
J. Clin. Gastroenterol., Jan;45(1):55-8 (2011)
Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome P-450 protein content.
Ann. Surg., Jun;251(6):1041-8 (2010)
Serum proteomic analysis of diet-induced steatohepatitis and metabolic syndrome in the Ossabaw miniature swine.
Am. J. Physiol. Gastrointest. Liver Physiol., May;298(5):G746-54 (2010)
Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease.
Hepatology., Jan;51(1):111-20 (2010)
Use of statins in patients with liver disease.
Curr Treat Options Cardiovasc Med., Aug;11(4):272-8 (2009)
Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.
Clin. Gastroenterol. Hepatol., Apr;7(4):481-6 (2009)
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management.
Hepatology., Jan;49(1):306-17 (2009)
Serum concentration-dependent hepatotoxicity in individuals receiving oral salsalate.
Dig. Dis. Sci., Jun;54(6):1375-6 (2009)
Therapeutic doses of acetaminophen frequently cause elevated aminotransferases in healthy volunteers: is it significant?
Gastroenterology., Apr;132(4):1624-6 (2007)
Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity.
Clin. Gastroenterol. Hepatol., Mar;5(3):388-93 (2007)
Relationship among histologic, radiologic, and biochemical assessments of hepatic steatosis: a study of human liver samples.
J. Clin. Gastroenterol., Feb;41(2):206-10 (2007)
Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States?
Am. J. Gastroenterol., Mar;102(3):558-62; quiz 693 (2007)
Isolated melanosis of the gastric antrum: an unusual endoscopic finding.
Clin. Gastroenterol. Hepatol., Jan;5(1):e2 (2007)
Restoration of bile ducts in drug-induced vanishing bile duct syndrome due to zonisamide.
Am. J. Surg. Pathol., Dec;30(12):1619-23 (2006)
Multicenter timolol study: the value of timolol and hemodynamic monitoring in the management of portal hypertensive cirrhotics with no esophageal varices.
Gastroenterology., Aug;131(2):674-6; discussion 676 (2006)
Statins for hyperlipidemia in patients with chronic liver disease: are they safe?
Clin. Gastroenterol. Hepatol., Jul;4(7):838-9 (2006)
Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study.
J. Clin. Endocrinol. Metab., Jun;91(6):2279-85 (2006)
Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study.
J. Clin. Gastroenterol., Mar;39(3):237-42 (2005)
Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes.
Am. J. Med. Sci., Feb;329(2):62-5 (2005)